Clinical Trial Update: Evaluation of Methods for the Determination of Chromogranin A in Routine Blood Samples [NA]

View source ↗

Summary

Completed clinical trial evaluating methods for determining Chromogranin A in routine blood samples in patients with neuroendocrine tumors (carcinoid).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Tumor

Snippet

Sponsor: University of Western Ontario, Canada | Conditions: Neuroendocrine Carcinoma (Carcinoid) | NA | Status: COMPLETED